Biotech/Pharma Companies in Raleigh-Durham-Chapel Hill
Check out the list of largest Biotech/Pharma Companies in the Triangle. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 18, 2020 Category: Pharmaceuticals Source Type: news

Don ’t foresee any disruptions due to Covid-19: Vasant Narasimhan, CEO, Novartis
Novartis is one of the oldest pharma MNCs known for anti-cancer and anti-diabetic drugs. Despite the patent expiry for its popular anti-diabetic drug Galvus, Narasimhan is upbeat about Novartis ’ India prospects. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 18, 2020 Category: Pharmaceuticals Source Type: news

In the money Feb. 17: $38M in deals for pharma, software businesses
Each week we wrap up recent funding activity, from company announcements to SEC filings. This time we found a $10 million round for an Austin cybersecurity company that comes with a partnership to a leading global consulting firm, as well as a band of angels coming together to support a startup that makes software for restaurants. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Mike Cronin Source Type: news

Bay Area women lead from lab to C-suite and beyond
A number of key women Bay Area life science leaders share their opinion on the state of the industry and how to bring more women into leadership. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Kevin Truong Source Type: news

Why a 'cultural shift' at Mount Carmel prompted cardiologists to leave for OhioHealth
A group of specialists decamping from one health system to another provide a glimpse into some of the debates within hospitals of how to weigh coordinated care with doctors' individualized decisions. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Carrie Ghose Source Type: news

UPMC commits $90M in investments to newest hospital in Maryland
UPMC has committed to investing $90 million over five years to the former Western Maryland Health System, which on its acquisition earlier this month became UPMC Western Maryland. The hospital system, based in Cumberland near the Pennsylvania border, now a tighter integration with the Pittsburgh-based UPMC that includes not only UPMC Hillman Cancer Center but also nearby hospitals like UPMC Altoona and UPMC Bedford. It had been clinically affiliated with UPMC since 2018. T here were no specific… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

Sneak Peek: Inside the Cone Women's and Children's Center, which opens Sunday (PHOTOS)
The six-floor, 195,678-square-foot addition to the Moses H. Cone Hospital in Greensboro cost $100 million. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: John Joyce Source Type: news

Banner Health adds orthopedic group to Phoenix network
Phoenix-based Banner Health is buying an orthopedic practice that will add 27 new providers to its employed medical group. Banner signed a purchase agreement of The Orthopedic Clinic Association, or TOCA. Once the transaction is complete, the group will be named TOCA at Banner Health and maintain its existing offices in Tempe, Scottsdale, Glendale and Phoenix. Its 18 orthopedic physicians and nine physician assistan ts will have privileges at Banner hospitals and ambulatory surgery centers throughout… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Angela Gonzales Source Type: news

AHN Wexford hospital to get state-of-the-art combined heat power plant
The project is being designed and will be run through a partnership with Peoples Natural Gas. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Paul J. Gough Source Type: news

How this CEO keeps doubling her organization's size
This Central Florida leader continues to pave a new future for the Florida Autism Center, including big growth plans within and outside its walls. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Richard Bilbao Source Type: news

Hospitals, health care providers have $100M in projects underway
Nearly $100 million in construction and renovation projects are underway or planned at area hospitals and health care providers throughout Western New York. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 17, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

Amid Coronavirus outbreak, India mulls export ban on 12 essential drugs
An eight-member expert committee constituted by the government to assess availability of medicines in the country has suggested imposing export restrictions on 12 drugs including antibiotics like chloramphenicol, neomycin, metronidazole, azythromicin, clindamycin; vitamin B1, B2 and B6; as well as hormones like progesterone used during pregnancy and in menstrual related problems. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2020 Category: Pharmaceuticals Source Type: news

Could COVID-19 Spur A Revolution In Vaccine Development?
A number of companies are using new biotechnology to rapidly deploy vaccines for the COVID-19 coronavirus. If they are successful, it will herald a revoution. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 16, 2020 Category: Pharmaceuticals Authors: Willy Shih, Contributor Source Type: news

Could The COVID-19 Spur A Revolution In Vaccine Development?
A number of companies are using new biotechnology to rapidly deploy vaccines for the COVID-19 coronavirus. If they are successful, it will herald a revoution. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 16, 2020 Category: Pharmaceuticals Authors: Willy Shih, Contributor Source Type: news

Podcast: Health care leaders discuss California Northstate's Elk Grove plans
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, panelists share their thoughts on the $750 million, 250-bed teaching hospital that for-profit California Northstate University has proposed in Elk Grove. The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 16, 2020 Category: Biotechnology Source Type: news

Unichem, Macleods Pharma recall drugs from US market
Drug firms Unichem Pharmaceuticals and Macleods Pharma are recalling various lots of tablets used for treatment of high blood pressure and diabetes from the US market, according to a latest enforcement report of the American health regulator. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 16, 2020 Category: Pharmaceuticals Source Type: news

OHSU uses deep brain stimulation to cure common tremor condition
A 79-year-old man who had the surgery called it a "life changer." (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Podcast: Health care consolidation, mergers and acquisitions
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, panelists discuss how consolidation, mergers and acquisitions affect the cost of health care and the ability to provide care in the most efficient manner. The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Source Type: news

Podcast: Here's an update on Aggie Square
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, UC Davis Health CEO Dr. David Lubarsky gives an update on Aggie Square, a planned UC Davis satellite campus and biotech hub in Sacramento. The event's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Source Type: news

Podcast: Here's an update on Aggie Square
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, UC Davis Health CEO Dr. David Lubarsky gives an update on Aggie Square, a planned UC Davis satellite campus and biotech hub in Sacramento. The event's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 15, 2020 Category: Pharmaceuticals Source Type: news

Podcast: Are we facing a shortage of health care workers?
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, panelists discuss industry challenges regarding the supply of doctors and other medical professionals. The panelists are Dr. David Lubarsky of UC Davis… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Source Type: news

DOH: Japanese man who visited Hawaii tests positive for coronavirus
A Japanese man who recently visited the Islands on vacation and has since returned to Japan has been confirmed as testing positive for the coronavirus (COVID-19), state officials announced in a briefing Friday afternoon. "What we know at this time is that an adult male traveler was in Hawaii from Jan. 28 through Feb. 7 and that when he returned to his home in Japan, it was confirmed that he had the COVID-19 virus," said Gov. David Ige at the briefing. Ige, along with state health director Bruce… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Authors: Olivia Peterkin Source Type: news

Podcast: Possible local impact of coronavirus
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. In this episode of the podcast series, panelists discuss the coronavirus as it relates to Sacramento.  The panelists are Dr. David Lubarsky of UC Davis Health, Trish Rodriguez of Kaiser Permanente,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Source Type: news

Coronavirus fears kill Facebook summit at San Francisco's Moscone Center
Facebook Inc. said Friday that it will nix a San Francisco event it had planned in March due to possible health issues from the fast-spreading coronavirus. “Our priority is the health and safety of our teams, so out of an abundance of caution, we cancelled our Global Marketing Summit due to evolving public health risks related to coronavirus," Facebook spokesman Anthony Harrison stated in an email to the San Francisco Business Times, a sister publi cation of the Silicon Valley Business Journal. The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Authors: Ted Andersen Source Type: news

Editor's notebook: Where Sacramento's health system may be worse than the nation's
The Health Care Leadership Forum, which we held last week at the Hyatt Regency Sacramento, is one of my favorite Business Journal events. I moderate a panel discussion of some of the top local executives in Sacramento's top private industry, health care, in front of a live audience. Interviewing health care executives is challenging. Leaders from each of the four major health systems represented at this year's event — Kaiser Permanente, Sutter Health, Dignity Health and UC Davis Health — are… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 15, 2020 Category: Biotechnology Authors: Adam Steinhauer Source Type: news

Novel coronavirus: The hunt for a virus killer
Some vaccine candidates for China virus are already at trial stage. But path to pharmacy is strewn with hurdles. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2020 Category: Pharmaceuticals Source Type: news

Covid-19 Impact: Pharma companies feel the pain as prices of key inputs shoot up
According to the data available with Pharmaceutical Export Promotion Council (Pharmexcil), the cost of paracetamol has gone up from Rs 250-300 kg to 400-450 kg. “Similarly, ‘montelukast sodium’ (an anti-asthma drug) is trading between Rs 52,000 and Rs 58,000 per kg, compared with Rs 33,000-38,000 per kg a few months ago. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 15, 2020 Category: Pharmaceuticals Source Type: news

Executive of the Year 2020: Sara Fritsch, Schoolhouse
Fritsch is president of Schoolhouse, a lighting manufacturer and lifestyle brand. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Sexual wellness startup launches on Valentine's Day with $5M seed round
A new app called Lover launched today — Valentine's Day — aimed at helping you up your game in the bedroom with “science-based” advice, guides and love-making improvement exercises. At the same time of the launch, the San Francisco company said it had closed a $5 million seed round, led by Lerer Hippea, an early-stage ventur e capital fund in New York. Sean Rad, co-founder and former CEO of Tinder, also invested. “We want to do for sexual health what apps like Calm and Headspace have… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Brian Rinker Source Type: news

Podcast: Top executives discuss the state of health care in Sacramento
The Sacramento Business Journal's annual Health Care Leadership Forum highlights the issues, concerns and opportunities for change in the local health care industry. This live panel discussion includes four health care system leaders in the region. The event was held Feb. 6 at the Hyatt Regency Sacramento. Listen to this first episode in the podcast series as Dr. David Lubarsky of UC Davis Health, Trish Rodriguez of Kaiser Permanente, Mark Behl of Dignity Health Medical Foundation and Brian Alexander… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Source Type: news

Big players in Wake County health care miss out, again, on expansion
In the latest battle for highly coveted Wake County operating rooms, the region's largest providers were all denied by state regulators in favor of smaller speciality providers. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Seth Thomas Gulledge Source Type: news

Opinion: Coronavirus reminds us to stress test our disaster preparedness
From a personal health risk perspective, the spread of the coronavirus in the United States is, for now, not of major concern. However, from a business perspective, now is the time to do contingency and preparedness planning. As an emergency manager who focuses 100 percent of my time on disaster resilience, I had always thought that for Western Washington earthquake hazards were our worst-case disaster events. That was true until April 10, 1990, which is the date when I attended a presentation by… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Eric Holdeman Source Type: news

CloudCath raises $12M to improve at-home dialysis monitoring
Catheter treatments are lifesaving medical procedures for draining fluids from the body. But because a catheter, or tube, is inserted into the body, there is a risk of infection, which can lead to hospitalization and the need for even more invasive treatments. That’s where CloudCath comes in, a maker of remote monitoring devices aimed at improving infection detection for treatments that involve a catheter. The San Francisco startup announced today that it has raised a $12 million Series A round… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Brian Rinker Source Type: news

Charlotte group adds to its Triangle portfolio with $10M buy
A Charlotte company dealing in health care real estate has expanded its presence in the Triangle by acquiring a surgery center. Flagship Healthcare Properties bought the Blue Ridge Surgery Center off Wesvill Court in Raleigh this month. The company paid $10.4 million for the outpatient surgical facility.  The property is situated on 2 acres at 2308 Wesvill Court just down the road from the UNC REX Hospital and within wal king distance of The Marketplace of Lake Boone and Lake Boone Shopping Center.  The… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Caleb Harshberger Source Type: news

Variety has prepared her for a ‘transformational’ tech role with a health care giant
Angela Yochem, EVP and chief digital officer for Novant Health, has had an impressive and extensive career with companies in varied industries such as Rent-A-Center, BDP International, AstraZeneca and Bank of America — just to name a few. She said her ability to bring about lasting change is the common thread that holds all of these jobs together. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Rob Schneider Source Type: news

North Texas' hospitals are predominantly corporate-owned
North Texas hospitals are predominantly corporate-owned, with nearly a third of the state ’s incorporated hospitals in the region. More than 50 hospitals across Collin, Cooke, Dallas, Denton, Ellis, Grayson, Johnson, Kaufman, Parker, Rockwall, Tarrant and Wise Counties are owned by a corporation, according to information was obtained from The Texas Department of State Health Services . Of the 144 hospitals in the region, the majority were affiliated with Baylor Scott& White, Medical City, … (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Dallas Business Journal staff Source Type: news

ECMC opens expanded atrium under the sun
Exactly three years to the day that Erie County Medical Center announced a $1 million gift from Russell Salvatore, the hospital on Valentine's Day opened a new front entrance and atrium named for the philanthropist. The new entrance is part of a larger campus-wide enhancements that include the $58 million emergency and trauma center as well as new windows throughout the Grider Street facility. In all, ECMC is spending more than $100 million on the projects. Hundreds of employees, staff and guests… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Tracey Drury Source Type: news

Partners hints at cost of rebrand, set to start this summer
The rebranding for the state's biggest health system is set to get underway this summer. Partners HealthCare still hasn't disclosed the projected cost, though a top executive hinted at the number on Friday. Partners is switching to Mass General Brigham in a nod to its two flagship hospitals, Mass. General and Brigham and Women's. Partners HealthCare announced the name change in late November. The Boston Business Journal first reported that the health system was considering the name change in June. Health… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Jessica Bartlett Source Type: news

North Texas Hospitals
Information on The List was obtained from The Texas Department of State Health Services ’ 2019 Texas Hospitals List. Only hospitals in North Texas with acute car beds. Information was pulled on Feb. 11, 2020. The Dallas Business Journal defines local as any companies within Collin, Cooke, Dallas, Denton, Ellis, Grayson, Johnson, Kaufman, Parker, Rockwall, Tarrant and Wise counties. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Source Type: news

Custom chemistry business expanding in Shelby County
A local custom chemistry business is expanding its presence in metro Birmingham. Therachem MediLab recently received incentives from the Chelsea City Council and Shelby County and now can move forward with developing a 4,000-square-foot facility on a 40,608-square-foot parcel of land at the Chelsea Business Park. It plans to break ground in August, with at least a year of cons truction. Therachem first opened its 6,600-square-foot facility at 100 Jade Park in 2018. The company also has a lab that… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Tyler Patchen Source Type: news

Biotech firm Novacyt to launch coronavirus test next week
Biotechnology company Novacyt said on Friday it would launch a certified test for the coronavirus next week, sending its London-listed shares to a record high. (Source: Reuters: Health)
Source: Reuters: Health - February 14, 2020 Category: Consumer Health News Tags: healthNews Source Type: news

Q BioMed debuts radiopharmaceutical for cancer pain
Biotech company Q BioMed has debuted a new therapeutic radiopharmaceutical...Read more on AuntMinnie.comRelated Reading: Q BioMed, Jubilant Radiopharma to partner (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 14, 2020 Category: Radiology Source Type: news

Seattle biotech leads work on coronavirus vaccine candidate
A Seattle-based biotech and partners are developing a vaccine for the coronavirus using RNA-based technology and hope to bring it into human trials this year. The coronavirus began late last year in Wuhan, China, and was first confirmed in the United States in January. So far, there are more than 400 possible cases across 41 states, according to the Centers for Disease Control. Seattle-based HDT BioCorp, which is working with various partners to advan ce a vaccine to human trials this year, is… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 14, 2020 Category: Biotechnology Authors: Megan Campbell Source Type: news

13.02.20: Bayer Driving Agricultural Innovation and Sustainability with Industry-Leading Pipeline and Investment
Bayer Driving Agricultural Innovation and Sustainability with Industry-Leading Pipeline and InvestmentNew herbicide molecule in early development announced; first new post-emergence mode of action for broad acre weed control in 30 years / Bayer unveils a third pathway to breakthrough short stature corn through gene editing; two prior concepts advance to Phase 3 / Three generations of herbicide-tolerance traits in soybeans advance phases, representing the industry's most robust pipeline of weed control biotechnology for soy / Largest agricultural industry R&D investment of more than 2.3 billion euros annuallymehr ... (S...
Source: Bayer IR Newsfeed: Events - February 14, 2020 Category: Pharmaceuticals Source Type: news

Seattle biotech leads work on coronavirus vaccine candidate
A Seattle-based biotech and partners are developing a vaccine for the coronavirus using RNA-based technology and hope to bring it into human trials this year. The coronavirus began late last year in Wuhan, China, and was first confirmed in the United States in January. So far, there are more than 400 possible cases across 41 states, according to the Centers for Disease Control. Seattle-based HDT BioCorp, which is working with various partners to advan ce a vaccine to human trials this year, is… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - February 14, 2020 Category: Pharmaceuticals Authors: Megan Campbell Source Type: news

Drug marketers to be held responsible for quality
Pharmaceutical companies that market medicines made by third parties in the country will now be held responsible for drug product quality with the health and family welfare ministry on Thursday issuing a notification to this effect. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 14, 2020 Category: Pharmaceuticals Source Type: news

Why the Port of Oakland doesn't have to worry about the coronavirus — yet
Amid suspended flights and tightened travel restrictions, one major connection between the Bay Area and China for now remains fully open: Cargo traffic through the Port of Oakland. Port Communications Director Mike Zampa said the coronavirus crisis has as yet had no effect on the 30% of cargo that the port unloads from China. “For now, it’s business as usual,” he said. “There’s been no disruption in cargo operations.” In fact, he said the port saw an increase i n volume by 7.3% (exports… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2020 Category: Biotechnology Authors: Brian Rinker Source Type: news

Q-and-A: Legacy's mental health director on Unity's troubles and possible solutions
Lynnea Lindsey said the situation is easing but patients are still waiting too long for beds. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

Portland addiction treatment startup ready to go national with Blue Cross partnership
Boulder Care is taking buprenorphine to underserved areas, with ambitious growth plans. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2020 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

CloudCath raises $12M to improve at-home dialysis monitoring
Catheter treatments are lifesaving medical procedures for draining fluids from the body. But because a catheter, or tube, is inserted into the body, there is a risk of infection, which can lead to hospitalization and the need for even more invasive treatments. That’s where CloudCath comes in, a maker of remote monitoring devices aimed at improving infection detection for treatments that involve a catheter. The San Francisco startup announced today that it has raised a $12 million Series A round… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - February 13, 2020 Category: Biotechnology Authors: Brian Rinker Source Type: news